166 related articles for article (PubMed ID: 14702129)
1. Ocular side effects associated with bisphosphonates.
Fraunfelder FW
Drugs Today (Barc); 2003 Nov; 39(11):829-35. PubMed ID: 14702129
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate-associated scleritis: a case report and review.
Leung S; Ashar BH; Miller RG
South Med J; 2005 Jul; 98(7):733-5. PubMed ID: 16108245
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study.
Etminan M; Forooghian F; Maberley D
CMAJ; 2012 May; 184(8):E431-4. PubMed ID: 22470169
[TBL] [Abstract][Full Text] [Related]
4. Ocular Side Effects of Bisphosphonates: A Review of Literature.
Chartrand NA; Lau CK; Parsons MT; Handlon JJ; Ronquillo YC; Hoopes PC; Moshirfar M
J Ocul Pharmacol Ther; 2023; 39(1):3-16. PubMed ID: 36409537
[TBL] [Abstract][Full Text] [Related]
5. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
French DD; Margo CE
Retina; 2008 Jun; 28(6):889-93. PubMed ID: 18536608
[TBL] [Abstract][Full Text] [Related]
6. Risedronate-associated scleritis: a case report and review of the literature.
Hemmati I; Wade J; Kelsall J
Clin Rheumatol; 2012 Sep; 31(9):1403-5. PubMed ID: 22864810
[TBL] [Abstract][Full Text] [Related]
7. Posterior uveitis: an under-recognized adverse effect of pamidronate: 2 case reports.
Haverbeke G; Pertile G; Claes C; Zeyen T
Bull Soc Belge Ophtalmol; 2003; (290):71-6. PubMed ID: 14750233
[TBL] [Abstract][Full Text] [Related]
8. Scleritis and other ocular side effects associated with pamidronate disodium.
Fraunfelder FW; Fraunfelder FT; Jensvold B
Am J Ophthalmol; 2003 Feb; 135(2):219-22. PubMed ID: 12566027
[TBL] [Abstract][Full Text] [Related]
9. [Bisphosphonate-induced ocular and orbital inflammation].
Jakobsen TS; Funding M
Ugeskr Laeger; 2022 Jul; 184(28):. PubMed ID: 35959811
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates: uveitis and scleritis.
Prescrire Int; 2013 May; 22(138):128. PubMed ID: 23819179
[No Abstract] [Full Text] [Related]
11. Scleritis complicating zoledronic acid infusion.
Benderson D; Karakunnel J; Kathuria S; Badros A
Clin Lymphoma Myeloma; 2006 Sep; 7(2):145-7. PubMed ID: 17026827
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced ocular inflammatory diseases.
Fraunfelder FW
Drugs Today (Barc); 2007 Feb; 43(2):117-23. PubMed ID: 17353948
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates: from grandparents to grandchildren.
Srivastava T; Alon US
Clin Pediatr (Phila); 1999 Dec; 38(12):687-702. PubMed ID: 10618761
[TBL] [Abstract][Full Text] [Related]
14. [BISPHOSPHONATES AND OCULAR INFLAMMATION].
Rappoport D; Leiba H
Harefuah; 2017 Feb; 156(2):71-73. PubMed ID: 28551891
[TBL] [Abstract][Full Text] [Related]
15. Scleritis and Intraorbital Inflammation following Oral and Intravenous Bisphosphonates in a 66-Year-Old Man.
Heck K; Malinina S; Palmowski A
Klin Monbl Augenheilkd; 2024 Apr; 241(4):426-428. PubMed ID: 38653272
[No Abstract] [Full Text] [Related]
16. The pharmacology and therapeutic utility of bisphosphonates.
Lourwood DL
Pharmacotherapy; 1998; 18(4):779-89. PubMed ID: 9692651
[TBL] [Abstract][Full Text] [Related]
17. Pamidronate disodium and possible ocular adverse drug reactions.
Macarol V; Fraunfelder FT
Am J Ophthalmol; 1994 Aug; 118(2):220-4. PubMed ID: 8053468
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of long-term bisphosphonates in postmenopausal osteoporosis.
Miller PD
Expert Opin Pharmacother; 2003 Dec; 4(12):2253-8. PubMed ID: 14640924
[TBL] [Abstract][Full Text] [Related]
19. Ibandronate (Boniva): a new oral bisphosphonate.
Med Lett Drugs Ther; 2005 Apr; 47(1207):35. PubMed ID: 15843783
[TBL] [Abstract][Full Text] [Related]
20. [Osteonecrosis of the jaws and bisphosphonates].
Junod AF; Carrel JP; Richter M; Vogt-Ferrier N
Rev Med Suisse; 2005 Nov; 1(39):2537-40, 2542-3. PubMed ID: 16323736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
